Eribulin inhibits cell growth in cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft harboring TP53 and ARID2 mutations

JOURNAL OF INVESTIGATIVE DERMATOLOGY(2023)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要